One evening, you tune in to your favourite medical drama. As the scene opens, the calm of the hospital is
Continue reading »
AI, wearables, interoperability new products at HIMSS19
Health IT vendors galore have been introducing new products this week at HIMSS19. Here is another selection of some of
Continue reading »
Excel Medical delivers new MDI solution for Epic's EHR
Medical device integration and analytics vendor Excel Medical, a company that markets technologies designed to eradicate unexpected deaths in hospitals,
Continue reading »
How 'cranky comments' can help spot CDS alert errors
It’s an all too common occurence for clinical decision support alerts to misfire or otherwise malfunction. And that’s a common
Continue reading »
Anti-CD47 cancer therapy safe, shows promise in small clinical trial
A novel immunotherapy appears safe for use in patients with a type of blood cancer called non-Hodgkin’s lymphoma, according to
Continue reading »
Functional engineered oesophagus could pave way for clinical trials
The world’s first functional oesophagus engineered from stem cells has been grown and successfully transplanted into mice, as part of
Continue reading »
Digital health fills care gaps for mental health patients
Comprehensive Mental Health Services in Independence, Missouri partnered with mental health IT vendor myStrength, a digital behavioral healthcare platform to
Continue reading »
Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
Oxford, UK, and Cambridge, MA, US, 3 August 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the publication
Continue reading »
NextFlex invests $12 million into health monitoring systems, other innovations
San Jose, California-based NextFlex announced that it is investing $12 million to take on seven initiatives, three of which are
Continue reading »
BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
AIRPORT CITY, Israel, July 11, 2018 /PRNewswire/ — BioSight Ltd., a pharmaceutical development company focused on the development of targeted
Continue reading »